Reversible polymer/metal nano-composites and method for manufacturing same

Information

  • Patent Grant
  • 8349964
  • Patent Number
    8,349,964
  • Date Filed
    Thursday, March 13, 2008
    16 years ago
  • Date Issued
    Tuesday, January 8, 2013
    11 years ago
Abstract
The present invention provides a polymer/metal nano-composite. The nano-composite includes at least one copolymer chain having alkenyl monomer units and maleimide monomer units, and a nano-sized metal or inorganic crystal. It also provides a method of producing nano-sized metal/inorganic crystals in pure form. These nano-composites and nano-crystals can be useful as polymer fillers, tire rubber compounds, semiconductors, nano-magnets, catalysts, and quantum dots etc.
Description
BACKGROUND OF THE INVENTION

The present invention relates to polymer nanoparticles, methods for their preparation, and their use as, for example, templates for the formation of nano-sized metal/inorganic crystals and nanocomposites.


Nanoparticles have attracted increased attention over the past several years in a variety of fields including catalysis, combinatorial chemistry, protein supports, magnets, and photonic crystals. Nano-scale metal composites have also been used advantageously in a variety of fields including, but not limited to, information technology, medicine and health, material and manufacturing, aeronautics and space exploration, environmental, energy fields, and snow/wet traction improvement for tire rubbers. Formation of nano-scale metal composites has often proven difficult due to the expense and difficulty of creating known templates, as well as the often difficult step of separating the composites from the template.


Accordingly, it would be desirable to develop polymer nano-micelle particles with desirable core and surface characteristics and size. It would also be desirable to develop a process for using these nanoparticles as templates to produce nano-scale metal composites and nano-sized metal/inorganic crystals in pure form.


SUMMARY OF THE INVENTION

In one embodiment of the present invention, a method for forming a polymer nano-micelle particle is provided. The method includes forming a copolymer comprising alkenyl monomer units and maleimide monomer units in a dry state, placing the copolymer into a non-polar solvent, and allowing the copolymer chains to form micelles.


In another embodiment, a method for forming metal nanocomposites is provided. The method includes forming a copolymer comprising alkenyl monomer units and alkyl maleimide monomer units in a dry state, placing the copolymer into a non-polar solvent and allowing the copolymer chains to form micelles. At least one metal in solution is added to the solvent containing micelles, thereby allowing the metal to complex with the copolymer chains in the desired concentrations, forming the metal nanocomposites.


A third embodiment, the present invention provides a method comprised of dissolving the polymer particles in a suitable solvent, thereby obtaining nano-sized metal/inorganic crystals in pure form, and regenerating the polymer.


The following definitions apply herein throughout unless a contrary intention is expressly indicated:

    • “vinyl aromatic hydrocarbon” and “alkenyl benzene” are used interchangeably;
    • “maleic anhydride” encompasses dicarboxylic acids, including maleic anhydride that can form a copolymer with an alkenyl benzene, an R1R2-ethylene, or an alkyl vinyl ether, the copolymer having dicarboxylic acid units capable of reaction with an amine functional group;
    • “maleimide” encompasses the reaction product of an amine and the dicarboxylic acids described above;
    • “R1R2-ethylene” encompasses compounds of the general formula:




embedded image



where R1 and R2 are the same or different substituents on the same or different carbon atoms of the ethylene group, and are independently H or substituted C1-C20 alkyl groups; and

    • poly(alkenyl-co-maleimide) includes, for example, poly(alkenylbenzene-co-maleimide), poly(R1R2-ethylene-co-maleimide), and poly(alkyl vinyl ether-co-maleimide).





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a transmission electron microscopy (TEM) photograph of metal nanocomposites formed in accordance with EXAMPLE 6.



FIG. 2 is a TEM photograph of metal nanocomposites formed in accordance with EXAMPLE 7.





DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS GENERAL NANOPARTICLE PROCESS OF FORMATION

One exemplary polymer nanoparticle of the present invention is formed from polymer chains. Preferred polymers include alkylmaleimides. The copolymers are preferably poly(alkenyl-co-maleimide)s and may optionally be crosslinked to form the desired polymer nanoparticles. The polymer nanoparticles have diameters—expressed as a mean average diameter—that are preferably less than about 100 nm, more preferably less than about 75 nm, and most preferably less than about 50 nm. The polymer nanoparticles preferably are substantially monodisperse and uniform in shape. The dispersity is represented by the ratio of Mw to Mn, with a ratio of 1 being substantially monodisperse. The polymer nanoparticles of the present invention preferably have a dispersity less than about 2.5, more preferably less than about 2.2, and most preferably less than about 1.8. Moreover, the polymer nanoparticles are preferably spherical, though shape defects are acceptable. The formation of polymer nanoparticles is preferably reversible. The reversible process can be achieved by, for example, changing solvent, varying temperature, or altering pH value etc.


The poly(alkenyl-co-maleimide)s contain alkenyl contributed monomer units chosen from vinyl-substituted aromatic hydrocarbon, R1R2-ethylene, and/or alkyl vinyl ether. The copolymer further includes maleimide contributed monomer units.


Poly(alkenyl-co-maleimide)s and poly(alkenyl-co-maleic anhydride)s encompass random and stereospecific copolymers, including copolymers having a backbone with alternating alkenyl-contributed units (i.e., monomer units derived from an alkenyl group such as styrene) and maleimide- or maleic anhydride-contributed units (i.e., monomer units derived from a maleimide or a maleic anhydride). Such alternating structures typically are described as poly(alkenyl-alt-maleimide)s and poly(alkenyl-alt-maleic anhydride)s; however, these polymers are encompassed within the terms poly(alkenyl-co-maleimide)s and poly(alkenyl-co-maleic anhydride)s. Exemplary copolymers include copolymers with a ratio of about 50% alkenyl contributed monomer units and about 50% maleimide contributed monomer units. However, copolymers with at least about 20% alkenyl contributed monomer units are also contemplated for use.


Preferred vinyl-substituted aromatic hydrocarbon contributed monomer units of a poly(alkenylbenzene-co-maleimide) are preferably derived from one or more of styrene, α-methylstyrene, 1-vinyl-naphthalene, 2-vinyl-naphthalene, 1-α-methyl vinyl naphthalene, 2-α-methyl naphthalene, as well as alkyl, cycloalkyl, aryl, alkaryl, and aralkyl derivatives thereof, in which the total number of carbon atoms in the combined hydrocarbon is generally not greater than 18, as well as any di- or tri-vinyl aromatic hydrocarbons. Preferred vinyl aromatic hydrocarbons include styrene and/or α-methyl styrene.


Preferred R1 and R2 groups of R1R2-ethylene contributed monomer units and the alkyl groups of said alkyl vinyl ether contributed monomer units are independently selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, cyclopropyl, 2,2-dimethylcyclopropyl, cyclopentyl, cyclohexyl, methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, methoxyoctyl, methoxynonyl, ethoxydecyl, ethoxymethyl, ethoxyethyl, ethoxypropyl, ethoxybutyl, ethoxypentyl, ethoxyhexyl, ethoxyheptyl, ethoxyoctyl, ethoxynonyl, ethoxydecyl, propoxymethyl, propoxyethyl, propoxypropyl, propoxybutyl, propoxypentyl, propoxyheptyl, propoxyoctyl, propoxynonyl, propoxydecyl, butoxymethyl, butoxyethyl, butoxypropoyl, butoxybutyl, butoxypentyl, butoxyhexyl, butoxyheptyl, butoxyoctyl, butoxynonyl, butoxydecyl, pentyloxymethyl, pentyloxyethyl, pentyloxypropyl, pentyloxybutyl, pentyloxypentyl, pentyloxyhexyl, pentyloxyoctyl, pentyloxynonyl, pentyloxydecyl, hexyloxymethyl, hexyloxyethyl, hexyloxypropyl, hexyloxybutyl, hexyloxypentyl, hexyloxyhexyl, hexyloxyheptyl, hexyloxyoctyl, hexyloxynonyl, hexyloxydecyl, heptyloxymethyl, heptyloxyethyl, heptyloxypropyl, heptyloxybutyl, hexyloxypentyl, heptyloxyhexyl, heptyloxyheptyl, heptyloxyoctyl, heptyloxynonyl, heptyloxydecyl, octyloxymethyl, octyloxyethyl, octyloxypropyl, octyloxybutyl, octyloxypentyl, octyloxyhexyl, octyloxyheptyl, octyloxyoctyl, octyloxynonyl, decyloxymethyl, decyloxyethyl, decyloxypropyl, decyloxybutyl, decyloxypentyl, decyloxyhexyl, decyloxyheptyl, 1-methylethyl, 1-methylpropyl, 1-methylbutyl, 1-methylpentyl, 1-methylhexyl, 1-methylheptyl, 1-methyloctyl, 1-methylnonyl, 1-methyldecyl, 2-methylpropyl, 2-methylbutyl, 2-bethylpentyl, 2-methylhexyl, 2-methylheptyl, 2-methyloctyl, 2,3,3-trimethylbutyl, 3-methylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 2,3,3,4-tetramethylpentyl, 3-methylhexyl, or 2,5-dimethylhexyl.


Preferred R1R2-ethylene contributed monomer units of the poly(R1R2-ethylene-co-maleimide) include alkenes such as ethylene, propylene, butylene, isobutylene, pentene, hexene, heptene, etc., as well as any di- or tri-alkene, or mixtures thereof, with preference given to isobutylene.


Preferred alkyl vinyl ether contributed monomer units of the poly(alkyl vinyl ether-co-maleimide) include any alkyl vinyl ether such as methyl vinyl ether, ethyl vinyl ether, propyl vinyl ether, butyl vinyl ether, and any other alkyl vinyl ether wherein the number of carbons in the alkyl substituent is not greater than about 30, and mixtures thereof. A preferred alkyl vinyl ether is methyl vinyl ether.


The poly(alkenyl-co-maleimide) can be formed by reacting a poly(alkenyl-co-maleic anhydride) in the presence of ammonia or amines at temperatures from about 100° C. to about 300° C. and at a pressure from about slightly above vacuum to about 2000 kPa, under substantially dry conditions. Alternatively, the poly(alkenyl-co-maleic anhydride) may be mixed with a primary amine. The poly(alkenyl-co-maleic anhydride) may be prepared by any means known in the art for forming copolymers. Free radical polymerization is preferred, but other means are contemplated. The individual monomer units may be distributed in any of a random or alternating arrangement along the polymer backbone. Furthermore, the backbone may be linear or branched. The poly(alkeneyl-co-maleic anhydride) and ammonia or amines are preferably dry mixed in the absence of solvents in a suitable mixing apparatus such as a Brabender mixer. Purging the mixer with N2 prior to charging of the reactants can be beneficial. The amines or ammonia may be added in a single charge, or in sequential partial charges into the reactor containing a charge of poly(alkenyl-co-maleic anhydride). Preferably, the amine or ammonia is charged in a ratio of between about 0.8 to 1.0 moles of nitrogen (in the primary amine or ammonia) per monomer contributed units of maleic anhydride in the poly(alkenyl-co-maleic anhydride).


Suitable primary amines include but are not limited to alkyl amines; alkyl benzyl amines; alkyl phenyl amines; alkoxybenzyl amines; allyl aminobenzoates; alkoxy aniline; and other linear primary amines containing from 1 to about 50 carbon atoms, preferably about 6 to about 30 carbon atoms in the alkyl and alkoxy substituents in these primary amines. The alkyl and alkoxy substituents of the primary amines can be linear or branched, preferably linear, and saturated or unsaturated, preferably saturated. Exemplary amines include hexylamine, octylamine, and dodecylamine. Ammonia is the most preferred nitrogen source due to the improved solubility of the resulting product in the electrolyte solutions. The poly(alkenyl-co-maleimide) preferably has a weight-average molecular weight (Mw) between about 10,000 and 500,000, more typically between about 150,000 and 450,000.


After formation of the copolymers, they are dispersed in a non-polar solvent, such as a hydrocarbon solvent, leading to the formation of a micellar solution. Suitable solvents include aliphatic hydrocarbons, such as pentane, hexane, heptane, octane, nonane, decane, and the like, as well as alicyclic hydrocarbons, such as cyclohexane, methyl cyclopentane, cyclooctane, cyclopentane, cycloheptane, cyclononane, cyclodecane and the like. These hydrocarbons may be used individually or in combination.


With respect to the monomers and solvents identified herein, nano-sized micelle particles are formed by maintaining a temperature that is favorable to micelle formation in the selected solvent(s). More particularly, by maintaining suitable conditions, the nanoparticles will begin to form in the shape of micelles wherein the polar constituents of the copolymer chains, e.g., maleimide, preferentially form the center of the micelle and the non-polar constituents of the copolymer chains, e.g., the alkyl side chains radiate, outwardly therefrom. Exemplary temperatures for the polymers discussed herein are in the range of about −40 to 250° C., with a temperature in the range of about 0 to 150° C. being particularly preferred. As demonstrated in more detail below, the interaction of copolymer selection, temperature, and solvent facilitates the formation of the micelles and ultimately the desired nanoparticles.


Metal Nanocomposite Formation


Nano-sized micelle particles produced in accordance with the present invention may be advantageously utilized as templates in the formation of nano-sized metal nanocomposites and metal/inorganic crystals. The formation of metal nanocomposites is preferably carried out by exposing the nanoparticles to metal ions, preferably metal ions in solution. The metal ion is then complexed with imine groups located inside the nanoparticle. Nano-sized metal/inorganic crystals are formed by introducing a suitable agent, e.g. H2S, CO32− and etc., which may react with the metal ions to form crystals within the micelle particles. Advantageously, the condensed nature of the nanoparticles may restrict the growth of the metal nanocomposites, thus providing size control of the metal nanocomposites into nano-scales.


Metals contemplated for use in the present invention include those known in the art as useful in semiconductors, catalysts, magnetic and quantum dots etc., including but not limited to Cu, Ti, Fe, Cd, Ni, Pd, and mixtures thereof. The formation of the metal nanocomposites is preferably carried out at a temperature of between about 0 and 100° C., more preferably between about 0 and 50° C. Preferred solvents useful in the formation include toluene, tetrahydrofuran (“THF”), water, alcohol, and mixtures thereof.


Separation of the metal nano-composites from the nanocomposites is achieved by performing a solvent change. For example, a solvent in which the polymer chains within the nanoparticles are soluble may be utilized. Such a solvent would induce swelling, and possibly dissolving, of the nanoparticles, thus allowing separation of the nano-sized metal/inorganic crystals from the nanoparticles. Preferred solvents for the separation step include THF, HCCl3, CCl4, toluene, and mixtures thereof.


Nano-sized metal/inorganic crystals produced in accordance with the present invention preferably have a mean average diameter less than about 50 nm, more preferably less than about 20 nm, and most preferably less than about 10 nm.


Of course, the present inventive nano-sized metal/inorganic crystals are suited to applications including the medical field, e.g. drug delivery and blood applications, information technology, e.g. quantum computers and dots, aeronautical and space research, energy, e.g., oil refining and lubricants, and tire applications such as snow/wet traction improvements.


The following examples are provided to help illustrate the present invention. The examples are not provided to limit the scope of the invention defined by the appended claims.


EXAMPLES
Example 1
Preparation of Alkylmaleimide Copolymers

A N2 purged Brabender mixer (˜310 g capacity) equipped with Banbury blades was set to 10 rpm and 30° C. The mixer was then charged with 120 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 99.4 g of octyl amine (Aldrich, 99% purity). The mixture was agitated in the mixer for 10 minutes and then heated up at a rate about 10° C./min to 210° C. Once the temperature reached 125° C., agitation was stopped. After reaching a temperature of 210° C., the heating element was set to the isothermal condition. The agitation was then started and increased from 0 to 90 rpm at a rate of 10 rpm/min. Once the agitation speed reached 90 rpm, the temperature was set to 190° C. The mixing was continued isothermally for an additional 90 minutes, the heating element was then turned off and the polymer was allowed to cool down at a rate ˜4° C./min. The final product was removed from the mixer at 160° C.


Example 2

The experiment and the procedure of example 1 were repeated, except for a minor change of the chemicals used. The mixer was charged with 100 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 118.8 g of dodecyl amine (Aldrich, 95% purity).


Example 3

A nitrogen purged Brabender mixer (˜310 g capacity) equipped with Banbury blades was set to 20 rpm and 60° C. The mixer was charged with 85 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 146.8 g of octadecyl amine (Aldrich, 99% purity). The mixture was agitated in the mixer for 10 minutes and then heated up at a rate about 10° C./min to 200° C. Once the temperature reached 135° C., agitation was stopped. When the temperature reached 200° C., the heating element was set to the isothermal condition. The agitation was then started and increased from 0 to 120 rpm at a rate of 10 rpm/min. The mixing was continued isothermally for additional 160 minutes, the heating element was then turned off and the polymer was allowed to cool down at a rate ˜4° C./min. The final product was removed from the mixer at 160° C.


IR characteristic absorption peaks are 1701, 1770, 2855, 2926 cm−1. No trace of maleic anhydride absorption peaks (i.e., at 1779 and 1855 cm−1) and amino-group peaks (i.e., at 3330) were detected for these copolymers. The molecular weights of these products were measured by GPC in THF solution, using polystyrene as the standard. The results are listed below:

















Ex. 1
Ex. 2
Ex. 3





















Molecular weight, Mn
116k
98k
121



Polydispersity Mw/Mn
1.76
2.16
2.07



Intrinsic Viscosity in THF, 20° C.
0.75
0.72
0.75











Use of Alkylmaleimide Copolymers for Nano-Tech


Example 4

Two 40 mL bottles were charged with materials as described below. The bottles were named as bottles A and B, respectively. The material inside those bottles was named accordingly as material A and B.


A) 0.2009 g of the products from example 3 were added into 10.056 g dodecane solvent. After being stirred overnight, the alkylmaleimide copolymer was dissolved. The solution was highly translucent and colorless. The solution was then further diluted with addition additional 10.2 g of dodecane. The concentration of the solution was about 1%.


B) 0.5 g of CuAc2 was added into a 15 g of THF. After vigorous stirring for half hour, the CuAc2 was dissolved. The solution was highly translucent to light and was dark blue in color.


The material in bottle A was then charged with 1.0 mL of solution from bottle B. The resulting solution was light blue. Half of the solution was placed in a vacuum oven at 100° C. Further drying of the product under vacuum yielded a polymer-Cu complex film. The film was dark blue, but transparent to light, indicating that the size of Cu++ clusters in the film was in the nano-meter range.


Example 5

H2S gas was bubbled through the remaining solution in bottle A to fully convert the Cu++ ions to CuS. The solution was then purged with N2 to remove the excess of H2S. The resulting solution is dark colored, with no macroscopic precipitation of CuS from solution. This indicated that the CuS formed are nano-sized and remain within the nanoparticle. (If taking a pure dodecane solvent and then charging with the same amount of Cu++/THF solution, one would find that there was a macroscopic precipitation of CuS from the solution once bubbling H2S through the solution.) Finally, the CuS/polymer solution was placed in a vacuum oven at 100° C. Further drying of the product under vacuum yielded a polymer/nano-sized CuS composite. The material was black, but highly translucent to light.


Example 6

About 1 mL of the CuS/polymer solution, prepared according to example 5, was further diluted to 50 times with hexane solvent. A drop of the diluted solution was then coated on a graphed copper micro-grid. After the solvent was evaporated, the screen was examined by TEM (FIG. 1). The result demonstrates that the sizes of the particles are of nano-scales (the scale is 60 nm). The size of the CuS particles was about 5 to 10 nm in diameter.


Example 7

About 1 mL of the CuS/polymer solution, prepared according to example 5, was further diluted to 50 times with THF solvent. THF is known as a good solvent for alkylmaleimide copolymers. Once THF was added, the CuS nano-crystals aggregated and precipitated. After filtrated, a small amount of the CuS was re-dispersed into THF by ultrasound. A drop of the diluted solution was then coated on a graphed copper micro-grid. After the solvent was evaporated, the screen was examined by TEM (FIG. 2). The result demonstrates that using THF solvent in fact dissolves the polymer molecules surround the particle, and the resulting particles aggregate to sub-micrometers (the scale is 100 nm). This phenomenon is very important since it allows separation of the nano-sized metal/inorganic crystals from the alkylmaleimide copolymer nano-micelles and the solvent by using simple centrifuge or filtration. The polymer and the solvent can then be recycled or reused again. After separation the aggregated nano-sized metal/inorganic crystals can be re-dispersed into dodecane solvent via addition of the copolymer.


The invention has been described with reference to the exemplary embodiments. Modifications and alterations will occur to others upon reading and understanding the specification. The invention is intended to include such modifications and alterations insofar as they come within the scope of the disclosure and claims.

Claims
  • 1. A polymer metal composite nanoparticle comprising: a polymer including alkenyl monomer contributed units and maleimide monomer contributed units; anda metal molecule complexed to one or more of said maleimide monomer contributed units;wherein the maleimide monomer contributed units form a center of a micelle and the alkenyl monomer contributed units form side chains radiating outwardly from the center, wherein the metal molecule is inside the center of the micelle.
  • 2. The polymer metal composite nanoparticle of claim 1, wherein the polymer metal composite nanoparticle has a mean average diameter of less than about 100 nm.
  • 3. The polymer metal composite nanoparticle of claim 1 wherein the alkenyl monomer contributed units are side chains to a backbone of the polymer.
  • 4. The polymer metal composite nanoparticle of claim 1 wherein said metal is selected from Cu, Ti, Fe, Cd and mixtures thereof.
  • 5. The polymer metal composite nanoparticle of claim 1 wherein the metal molecule is part of a metal/inorganic crystal having a mean average diameter of about 50 nm to about 10 nm.
  • 6. The polymer metal composition nanoparticle of claim 1, wherein the alkenyl monomer units are selected from the group consisting of vinyl-substituted aromatic hydrocarbons, R1R2 ethylenes, alkyl vinyl ethers, and mixtures thereof.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. application Ser. No. 10/872,731, filed on Jun. 21, 2004 now abandoned. This prior application, is hereby incorporated into the present application by reference.

US Referenced Citations (225)
Number Name Date Kind
2531396 Carter et al. Nov 1950 A
3598884 Wei Aug 1971 A
3793402 Owens Feb 1974 A
3840620 Gallagher Oct 1974 A
3972963 Schwab et al. Aug 1976 A
4075186 Ambrose et al. Feb 1978 A
4233409 Bulkley Nov 1980 A
4247434 Vanderhoff et al. Jan 1981 A
4248986 Lal et al. Feb 1981 A
4326008 Rembaum Apr 1982 A
4386125 Shiraki et al. May 1983 A
4463129 Shinada et al. Jul 1984 A
4471093 Furukawa et al. Sep 1984 A
4543403 Isayama et al. Sep 1985 A
4598105 Weber et al. Jul 1986 A
4602052 Weber et al. Jul 1986 A
4659790 Shimozato et al. Apr 1987 A
4717655 Fluwyler Jan 1988 A
4725522 Breton et al. Feb 1988 A
4764572 Bean, Jr. Aug 1988 A
4773521 Chen Sep 1988 A
4774189 Schwartz Sep 1988 A
4788254 Kawakubo et al. Nov 1988 A
4829130 Licchelli et al. May 1989 A
4829135 Gunesin et al. May 1989 A
4837274 Kawakubo et al. Jun 1989 A
4837401 Hirose et al. Jun 1989 A
4861131 Bois et al. Aug 1989 A
4870144 Noda et al. Sep 1989 A
4871814 Gunesin et al. Oct 1989 A
4904730 Moore et al. Feb 1990 A
4904732 Iwahara et al. Feb 1990 A
4906695 Blizzard et al. Mar 1990 A
4920160 Chip et al. Apr 1990 A
4942209 Gunesin Jul 1990 A
4987202 Zeigler Jan 1991 A
5036138 Stamhuis et al. Jul 1991 A
5066729 Srayer, Jr. et al. Nov 1991 A
5073498 Schwartz et al. Dec 1991 A
5075377 Kawabuchi et al. Dec 1991 A
5120379 Noda et al. Jun 1992 A
5130377 Trepka et al. Jul 1992 A
5169914 Kaszas et al. Dec 1992 A
5194300 Cheung Mar 1993 A
5219945 Dicker et al. Jun 1993 A
5227419 Moczygemba et al. Jul 1993 A
5237015 Urban Aug 1993 A
5241008 Hall Aug 1993 A
5247021 Fujisawa et al. Sep 1993 A
5256736 Trepka et al. Oct 1993 A
5262502 Fujisawa et al. Nov 1993 A
5290873 Noda et al. Mar 1994 A
5290875 Moczygemba et al. Mar 1994 A
5290878 Yamamoto et al. Mar 1994 A
5296547 Nestegard et al. Mar 1994 A
5329005 Lawson et al. Jul 1994 A
5331035 Hall Jul 1994 A
5336712 Austgen, Jr. et al. Aug 1994 A
5362794 Inui et al. Nov 1994 A
5395891 Obrecht et al. Mar 1995 A
5395902 Hall Mar 1995 A
5399628 Moczygemba et al. Mar 1995 A
5399629 Coolbaugh et al. Mar 1995 A
5405903 Van Westrenen et al. Apr 1995 A
5421866 Stark-Kasley et al. Jun 1995 A
5436298 Moczygemba et al. Jul 1995 A
5438103 DePorter et al. Aug 1995 A
5447990 Noda et al. Sep 1995 A
5462994 Lo et al. Oct 1995 A
5514734 Maxfield et al. May 1996 A
5514753 Ozawa et al. May 1996 A
5521309 Antkowiak et al. May 1996 A
5525639 Keneko et al. Jun 1996 A
5527870 Maeda et al. Jun 1996 A
5530052 Takekoshi et al. Jun 1996 A
5580925 Iwahara et al. Dec 1996 A
5587423 Brandstetter et al. Dec 1996 A
5594072 Handlin, Jr. et al. Jan 1997 A
5614579 Roggeman et al. Mar 1997 A
5627252 De La Croi Habimana May 1997 A
5674592 Clark et al. Oct 1997 A
5686528 Wills et al. Nov 1997 A
5688856 Austgen, Jr. et al. Nov 1997 A
5707439 Takekoshi et al. Jan 1998 A
5728791 Tamai et al. Mar 1998 A
5733975 Aoyama et al. Mar 1998 A
5739267 Fujisawa et al. Apr 1998 A
5742118 Endo et al. Apr 1998 A
5747152 Oka et al. May 1998 A
5763551 Wunsch et al. Jun 1998 A
5773521 Hoxmeier et al. Jun 1998 A
5777037 Yamanaka et al. Jul 1998 A
5811501 Chiba et al. Sep 1998 A
5834563 Kimura et al. Nov 1998 A
5847054 McKee et al. Dec 1998 A
5849847 Quirk Dec 1998 A
5855972 Kaeding Jan 1999 A
5883173 Elspass et al. Mar 1999 A
5891947 Hall et al. Apr 1999 A
5905116 Wang et al. May 1999 A
5910530 Wang et al. Jun 1999 A
5955537 Steininger et al. Sep 1999 A
5986010 Clites et al. Nov 1999 A
5994468 Wang et al. Nov 1999 A
6011116 Aoyama et al. Jan 2000 A
6020446 Okamoto et al. Feb 2000 A
6025416 Proebster et al. Feb 2000 A
6025445 Chiba et al. Feb 2000 A
6060549 Li et al. May 2000 A
6060559 Feng et al. May 2000 A
6087016 Feeney et al. Jul 2000 A
6087456 Sakaguchi et al. Jul 2000 A
6106953 Zimmermann et al. Aug 2000 A
6117932 Hasegawa et al. Sep 2000 A
6121379 Yamanaka et al. Sep 2000 A
6127488 Obrecht et al. Oct 2000 A
6147151 Fukumoto et al. Nov 2000 A
6166855 Ikeyama et al. Dec 2000 A
6180693 Tang et al. Jan 2001 B1
6191217 Wang et al. Feb 2001 B1
6197849 Zilg et al. Mar 2001 B1
6204354 Wang et al. Mar 2001 B1
6207263 Takematsu et al. Mar 2001 B1
6225394 Lan et al. May 2001 B1
6252014 Knauss Jun 2001 B1
6255372 Lin et al. Jul 2001 B1
6268451 Faust et al. Jul 2001 B1
6277304 Wei et al. Aug 2001 B1
6348546 Hiiro et al. Feb 2002 B2
6359075 Wollum et al. Mar 2002 B1
6379791 Cernohous et al. Apr 2002 B1
6383500 Wooley et al. May 2002 B1
6395829 Miyamoto et al. May 2002 B1
6420486 DePorter et al. Jul 2002 B1
6437050 Krom et al. Aug 2002 B1
6441090 Demirors et al. Aug 2002 B1
6448353 Nelson et al. Sep 2002 B1
6489378 Sosa et al. Dec 2002 B1
6524595 Perrier et al. Feb 2003 B1
6573313 Li et al. Jun 2003 B2
6573330 Fujikake et al. Jun 2003 B1
6598645 Larson Jul 2003 B1
6649702 Rapoport et al. Nov 2003 B1
6663960 Murakami et al. Dec 2003 B1
6689469 Wang et al. Feb 2004 B2
6693746 Nakamura et al. Feb 2004 B1
6706813 Chiba et al. Mar 2004 B2
6706823 Wang et al. Mar 2004 B2
6727311 Ajbani et al. Apr 2004 B2
6737486 Wang May 2004 B2
6750297 Yeu et al. Jun 2004 B2
6759464 Ajbani et al. Jul 2004 B2
6774185 Hergenrother et al. Aug 2004 B2
6777500 Lean et al. Aug 2004 B2
6780937 Castner Aug 2004 B2
6835781 Kondou et al. Dec 2004 B2
6858665 Larson Feb 2005 B2
6861462 Parker et al. Mar 2005 B2
6872785 Wang et al. Mar 2005 B2
6875818 Wang Apr 2005 B2
6908958 Maruyama et al. Jun 2005 B2
6956084 Wang et al. Oct 2005 B2
7056840 Miller et al. Jun 2006 B2
7071246 Xie et al. Jul 2006 B2
7112369 Wang et al. Sep 2006 B2
7179864 Wang Feb 2007 B2
7193004 Weydert et al. Mar 2007 B2
7205370 Wang et al. Apr 2007 B2
7217775 Castner May 2007 B2
7238751 Wang et al. Jul 2007 B2
7244783 Lean et al. Jul 2007 B2
7291394 Winkler et al. Nov 2007 B2
7347237 Xie et al. Mar 2008 B2
7408005 Zheng et al. Aug 2008 B2
20010053813 Konno et al. Dec 2001 A1
20020007011 Konno et al. Jan 2002 A1
20020045714 Tomalia et al. Apr 2002 A1
20020095008 Heinrich et al. Jul 2002 A1
20020144401 Nogueroles Vines et al. Oct 2002 A1
20030004250 Ajbani et al. Jan 2003 A1
20030032710 Larson Feb 2003 A1
20030124353 Wang et al. Jul 2003 A1
20030130401 Lin et al. Jul 2003 A1
20030149185 Wang et al. Aug 2003 A1
20030198810 Wang et al. Oct 2003 A1
20030225190 Borbely et al. Dec 2003 A1
20040033345 Dubertret et al. Feb 2004 A1
20040059057 Swisher et al. Mar 2004 A1
20040091546 Johnson et al. May 2004 A1
20040127603 Lean et al. Jul 2004 A1
20040143064 Wang Jul 2004 A1
20040198917 Castner Oct 2004 A1
20050101743 Stacy et al. May 2005 A1
20050182158 Ziser et al. Aug 2005 A1
20050192408 Wang et al. Sep 2005 A1
20050197462 Wang et al. Sep 2005 A1
20050203248 Zheng et al. Sep 2005 A1
20050215693 Wang et al. Sep 2005 A1
20050228072 Winkler et al. Oct 2005 A1
20050228074 Warren et al. Oct 2005 A1
20050282956 Wang et al. Dec 2005 A1
20060084722 Bohm et al. Apr 2006 A1
20060173115 Fudemoto et al. Aug 2006 A1
20060173130 Wang et al. Aug 2006 A1
20060235128 Wang et al. Oct 2006 A1
20070027264 Wang et al. Feb 2007 A1
20070135579 Obrecht et al. Jun 2007 A1
20070142550 Scurati et al. Jun 2007 A1
20070142559 Wang et al. Jun 2007 A1
20070149649 Wang et al. Jun 2007 A1
20070161754 Wang et al. Jul 2007 A1
20070185273 Wang et al. Aug 2007 A1
20070196653 Hall et al. Aug 2007 A1
20080145660 Wang et al. Jun 2008 A1
20080149238 Kleckner et al. Jun 2008 A1
20080160305 Warren et al. Jul 2008 A1
20080188579 Wang et al. Aug 2008 A1
20080286374 Wang et al. Nov 2008 A1
20090005491 Warren Jan 2009 A1
20090048390 Wang et al. Feb 2009 A1
20090054554 Wang et al. Feb 2009 A1
20090270558 Gandon-pain et al. Oct 2009 A1
20100004398 Wang et al. Jan 2010 A1
20100016472 Wang et al. Jan 2010 A1
20100016512 Wang et al. Jan 2010 A1
Foreign Referenced Citations (48)
Number Date Country
2127919 Mar 1995 CA
3434983 Apr 1986 DE
4241538 Jun 1994 DE
0143500 Jun 1985 EP
0255170 Feb 1988 EP
0265142 Apr 1988 EP
0322905 Jul 1989 EP
0352042 Jan 1990 EP
0472344 Feb 1992 EP
0540942 May 1993 EP
0590491 Apr 1994 EP
0742268 Nov 1996 EP
1031605 Aug 2000 EP
1099728 May 2001 EP
1134251 Sep 2001 EP
1273616 Jan 2003 EP
1321489 Jun 2003 EP
1783168 May 2007 EP
2099645 Mar 1972 FR
01279943 Jan 1989 JP
2191619 Jul 1990 JP
2196893 Aug 1990 JP
05132605 May 1993 JP
06248017 Sep 1994 JP
7011043 Jan 1995 JP
08199062 Aug 1996 JP
2000-514791 Nov 2000 JP
2003-095640 Apr 2003 JP
2006-072283 Mar 2006 JP
2006-106596 Apr 2006 JP
2007-304409 Nov 2007 JP
9104992 Apr 1991 WO
9704029 Feb 1997 WO
9853000 Nov 1998 WO
0075226 Dec 2000 WO
0187999 Nov 2001 WO
0231002 Apr 2002 WO
02471987 May 2002 WO
0281233 Oct 2002 WO
02100936 Dec 2002 WO
03032061 Apr 2003 WO
03085040 Oct 2003 WO
2004058874 Jul 2004 WO
2006069793 Jul 2006 WO
2008014464 Jan 2008 WO
2008079276 Jul 2008 WO
2008079807 Jul 2008 WO
2009006434 Jan 2009 WO
Related Publications (1)
Number Date Country
20080305336 A1 Dec 2008 US
Divisions (1)
Number Date Country
Parent 10872731 Jun 2004 US
Child 12047896 US